IKS04, a CanAg-Targeting Antibody-Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models. - Huang H; Deckert J; Mysliwy J; Lodge A; Lutz RJ; Thurber GM (Molecular cancer therapeutics, 2025)